Walleye Capital’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-277,168
Closed -$2.69M 5090
2026
Q1
$2.69M Buy
277,168
+121,133
+78% +$1.11M 0.01% 1226
2025
Q4
$1.49M Buy
156,035
+155,972
+247,575% +$1.59M ﹤0.01% 2106
2025
Q3
$615 Sell
63
-1,995
-97% -$15.3K ﹤0.01% 4387
2025
Q2
$12.5K Buy
+2,058
New +$15.4K ﹤0.01% 4287
2025
Q1
Sell
-14,953
Closed -$207K 4952
2024
Q4
$207K Buy
+14,953
New +$236K ﹤0.01% 3731
2024
Q3
Sell
-46,098
Closed -$951K 5750
2024
Q2
$951K Buy
46,098
+44,879
+3,682% +$971K ﹤0.01% 2904
2024
Q1
$30.2K Buy
+1,219
New +$36.3K ﹤0.01% 4817
2023
Q4
Sell
-4,286
Closed -$207K 5389
2023
Q3
$207K Sell
4,286
-51,366
-92% -$3.05M ﹤0.01% 3532
2023
Q2
$3.8M Buy
+55,652
New +$3.59M 0.01% 903
2019
Q2
Sell
-7,319
Closed -$89K 1968
2019
Q1
$89K Buy
+7,319
New +$91.4K 0.01% 1071

Other funds holding PRTA

Walleye Capital's PRTA Position: Q2 2026 in Review

Walleye Capital sold out of Prothena Corp (PRTA) in Q2 2026, closing a stake of 277,168 shares — an estimated $2.69M sold.

Walleye Capital first reported a position in PRTA in Q1 2019 and held it in 10 quarters. The position peaked at $3.8M in Q2 2023. 188 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • Walleye Capital reported no remaining Prothena Corp position as of Q2 2026 after selling out during the quarter.
  • Walleye Capital sold 277,168 Prothena Corp shares in Q2 2026, an estimated $2.69M.
  • Walleye Capital first reported a position in Prothena Corp in Q1 2019 and held it in 10 quarters.
  • Walleye Capital's Prothena Corp position peaked at $3.8M in Q2 2023.
  • 188 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.